HSP90 acts as the molecular chaperone and is highly expressed in several therapy‐resistant leukemia subtypes, thereby ensuring correct protein folding of several oncogenic proteins such as BCR‐ABL1 and FLT3‐ITD. This evidence concerns the gene FLT3 and leukemia.